Related Experiment Video
Updated: Jul 15, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Obesity in critical care.
1The Trauma and Life Support Center, University of Wisconsin Hospital and Clinics, Section of Pulmonary and Critical Care Medicine, Madison, WI 53792, USA.
Current Opinion in Anaesthesiology
|April 7, 2007
Summary
Critically ill obese patients require specialized intensive care due to obesity-related organ dysfunction. Understanding these pathophysiologic effects is crucial for effective management and improved patient outcomes.
Area of Science:
- Critical Care Medicine
- Obesity Pathophysiology
- Clinical Management
Background:
- Obesity is a global health epidemic linked to significant morbidity and mortality.
- Chronic obesity causes physiological derangements in cardiovascular, respiratory, and metabolic systems.
- Obesity presents unique challenges in the intensive care unit (ICU) setting.
Purpose of the Study:
- To review literature on the care of critically ill obese patients.
- To emphasize the pathophysiology of obesity and its clinical management implications.
Main Methods:
- Literature review of studies concerning critically ill obese patients.
- Analysis of obesity's impact on physiological functions and clinical interventions.
Main Results:
- Obesity leads to cardiovascular, respiratory, and metabolic dysfunction.
- Drug efficacy depends on lipophilicity; vascular access may require ultrasound guidance.
- Accurate blood pressure monitoring may necessitate direct intraarterial methods.
Conclusions:
- Obesity affects all major organ systems, necessitating specific ICU care strategies.
- Clinicians must understand obesity's pathophysiologic effects to anticipate complications.
- Knowledge of obesity-related ICU issues enables timely and effective treatment for obese patients.
Related Concept Videos
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.